Queen Mary University of London - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
44
About the Report
About the Report
Summary
Queen Mary University of London (Queen Mary), formerly Queen Mary and Westfield College, a subsidiary of University of London, is a research university that offers undergraduate and postgraduate education; and research programs. The university provides graduation and education services in areas of astrophysics, biological and chemical sciences, business and management, comparative literature, computer science, drama, economics and finance; electronic engineering, english, film studies, law, linguistics, materials, mathematical sciences and others. It also provides national research assessments and research funding programs. The university provides education services to students in the UK and abroad. Queen Mary is headquartered in London, the UK.
Queen Mary University of London-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Queen Mary University of London, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Queen Mary University of London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Queen Mary University of London, Medical Devices Deals, 2012 to YTD 2018 10
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Queen Mary University of London, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Queen Mary University of London Enters into Research Agreement with Takeda Pharma 12
Cambridge University, Imperial College London, King's College London, Queen Mary University London, University College London and Oxford University Enter into Research and Development Agreement with Pfizer 13
Cancer Research Technology Enters Into Co-Development Agreement With ADC Therapeutics For Antibody Drug Conjugates 15
BioInvent And Cancer Research Technology Enter Into Co-Development Agreement With Queen Mary, University of London 17
MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University 18
Licensing Agreements 19
MultiVir Enters into Licensing Agreement with Queen Mary University of London 19
BioMoti Enters into Licensing Agreement with Queen Mary University of London 20
Acquisition 21
Retroscreen Virology Acquires Activiomics for USD6.7 Million 21
Queen Mary University of London-Key Competitors 23
Queen Mary University of London-Key Employees 24
Queen Mary University of London-Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Strategy And Business Planning 26
Sep 19, 2018: Cancer Research UK launches new research hub for biotherapeutics 26
Government and Public Interest 27
Sep 12, 2018: Study links common arthritis drug azathioprine to skin cancer 27
Aug 26, 2018: Blood pressure medications and statins found to provide long-term cardiovascular benefits 28
Aug 26, 2018: Long-term cardiovascular benefits following statins and blood pressure trial 29
Jun 06, 2018: New lab technology could reveal treatments for muscle-wasting disease 31
Feb 27, 2018: Switching on survival signalling to drive drug resistance 33
Feb 06, 2018: Research projected launched to crack aspirin's anti-cancer properties 34
Feb 05, 2018: Multinational companies continue to produce unregulated antibiotics in India 35
Dec 11, 2017: Weakness discovered in most common childhood brain cancer 36
Nov 21, 2017: Drug could put an end to transplant rejection 37
Jul 14, 2017: Queen Mary University of London: Awarded GBP8.6m for global health research 38
Feb 07, 2017: NattoPharma Named Partner For Horizon 2020 EU Research Grant 39
Product News 40
Dec 14, 2017: Groundbreaking gene therapy trial set to cure hemophilia 40
Mar 05, 2018: Aspirin helps treat tuberculous meningitis 42
Feb 16, 2018: New printing technique uses cells and molecules to recreate biological structures 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
List of Figure
List of Figures
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Queen Mary University of London, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
Queen Mary University of London, Pharmaceuticals & Healthcare, Key Facts 2
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Queen Mary University of London, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Queen Mary University of London, Deals By Therapy Area, 2012 to YTD 2018 9
Queen Mary University of London, Medical Devices Deals, 2012 to YTD 2018 10
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Queen Mary University of London Enters into Research Agreement with Takeda Pharma 12
Cambridge University, Imperial College London, King's College London, Queen Mary University London, University College London and Oxford University Enter into Research and Development Agreement with Pfizer 13
Cancer Research Technology Enters Into Co-Development Agreement With ADC Therapeutics For Antibody Drug Conjugates 15
BioInvent And Cancer Research Technology Enter Into Co-Development Agreement With Queen Mary, University of London 17
MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University 18
MultiVir Enters into Licensing Agreement with Queen Mary University of London 19
BioMoti Enters into Licensing Agreement with Queen Mary University of London 20
Retroscreen Virology Acquires Activiomics for USD6.7 Million 21
Queen Mary University of London, Key Competitors 23
Queen Mary University of London, Key Employees 24
Queen Mary University of London, Subsidiaries 25
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.